References
- Alavi S, Ashraf H, Rashidi A, et al (2006). Distribution of ABO blood groups in childhood acute leukemia. Pediatr Hematol Oncol, 23, 611-7. https://doi.org/10.1080/08880010600907221
- Alibhai SM, Leach M, Minden MD, et al (2009). Outcomes and quality of care in acute myeloid leukemia over 40 years. Cance, 115, 2903-11. https://doi.org/10.1002/cncr.24373
- Ashrafi F, Shahnazari R, Samimi MA, et al (2013). Results of treatment of acute myeloid leukemia in central part of Iran. Adv Biomed Res, 2, 51. https://doi.org/10.4103/2277-9175.114194
- Ayremlou P, Razavi SM, Solaymani-Dodaran M, et al (2012). Demographic and prognostic factors of 455 patients with acute leukemia admitted to two referral hospitals in tehran-iran during ten years (2001-2011). Iran J Cancer Prev, 5, 157-63.
- Byrd JC, Lawrence D, Arthur DC, et al (1998). Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461. Clin Cancer Res, 4, 1235-41.
- Cohen PL, Hoyer JD, Kurtin PJ, et al (1998). Acute myeloid leukemia with minimal differentiation. A multiple parameter study. Am J Clin Pathol, 109, 32-8. https://doi.org/10.1093/ajcp/109.1.32
- Douer D (2003). The epidemiology of acute promyelocytic leukemia. Best Practice Rea Clinical Haematol, 16, 357-67. https://doi.org/10.1016/S1521-6926(03)00065-3
- Eriksson U, Seifert B, Schaffner A (2001). Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial. BMJ, 322, 579-82. https://doi.org/10.1136/bmj.322.7286.579
- Estey E, Dohner H (2006). Acute myeloid leukaemia. Lancet, 368, 1894-907. https://doi.org/10.1016/S0140-6736(06)69780-8
- Ghosh S, Shinde SC, Kumaran GS, et al (2003). Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of tata memorial hospital. Indian J Cancer, 40, 71-6.
- Gillis S, Dann EJ, Rund D (1996). Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropenia. Am J Hematol, 51, 26-31. https://doi.org/10.1002/(SICI)1096-8652(199601)51:1<26::AID-AJH5>3.0.CO;2-9
- Girmenia C, Frustaci AM, Gentile G, et al (2012). Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience. Haematologica, 97, 560-7. https://doi.org/10.3324/haematol.2011.053058
- Hamill RJ (2013). Amphotericin B formulations: a comparative review of efficacy and toxicity. Drugs, 73, 919-34. https://doi.org/10.1007/s40265-013-0069-4
- Harani MS, Adil SN, Shaikh MU, et al (2005). Frequency of fab subtypes in acute myeloid leukemia patients at Aga Khan University Hospital Karachi. J Ayub Med Coll Abbottabad, 17, 26-9.
- Hassan K, Qureshi M, Shafi S, et al (1993). Acute myeloid leukemia-FAB classification and its correlation with clinico-haematological features. J Pak Med Assoc, 43, 200-3.
- Heil G, Hoelzer D, Sanz MA, et al (1997). A randomized, double-blind, placebo-controlled, phase III study of filgrastim in remission induction and consolidation therapy for adults with de novo acute myeloid leukemia. The International Acute Myeloid Leukemia Study Group. Blood, 90, 4710-8.
- Juliusson G, Antunovic P, Derolf A, et al (2009). Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish acute leukemia registry. Blood, 113, 4179-87. https://doi.org/10.1182/blood-2008-07-172007
- Lerch E, Espeli V, Zucca E, et al (2009). Prognosis of acute myeloid leukemia in the general population: data from southern Switzerland. Tumori, 95, 303-10. https://doi.org/10.1177/030089160909500306
- Mazloumi SH, Kumari P, Madhumathi DS, et al (2012). Rare and recurrent chromosomal abnormalities and their clinical relevance in pediatric acute leukemia of south Indian population. Indian J Med Paediatr Oncol, 33, 166-9. https://doi.org/10.4103/0971-5851.103144
- Merkel D, Filanovsky K, Gafter-Gvili A, et al (2013). Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study. Am J Hematol, 88, 130-4. https://doi.org/10.1002/ajh.23368
- Mrozek K (2008). Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype. Semin Oncol, 35, 365-77. https://doi.org/10.1053/j.seminoncol.2008.04.007
- Oran B, Weisdorf DJ (2012). Survival for older patients with acute myeloid leukemia: a population-based study. Haematologica, 97, 1916-24. https://doi.org/10.3324/haematol.2012.066100
- Pedersen-Bjergaard J, Andersen MK, Johansson B (1998). Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors. J Clin Oncol, 16, 1897-8. https://doi.org/10.1200/JCO.1998.16.5.1897
- Pulsoni A, Pagano L, Latagliata R, et al (2004). Survival of elderly patients with acute myeloid leukemia. Haematologica, 89, 296-302.
- Sepehrizadeh Z, Mohammadi M, Emami A, et al (2014). Assessment of cytokine expression profile in acute myeloid leukemia patients before and after chemotherapy. Turk J Haematol, 31, 149-54. https://doi.org/10.4274/tjh.2012.0164
- Shipley JL, Butera JN (2009). Acute myelogenous leukemia. Exp Hematol, 37, 649-58. https://doi.org/10.1016/j.exphem.2009.04.002
- Spitzer TR, Creger RJ, Fox RM, et al (1989). Rapid infusion amphotericin B: effective and well-tolerated therapy for neutropenic fever. Pharmatherapeutica, 5, 305-11.
- Stone RM, O’Donnell MR, Sekeres MA (2004). Acute myeloid leukemia. Hematol Am Soc Hematol Educ Program. 2004, 98-117.
- Strom SS, Oum R, Elhor Gbito KY, et al (2012). De novo acute myeloid leukemia risk factors: a Texas case-control study. Cancer, 118, 4589-96. https://doi.org/10.1002/cncr.27442
- Vadivelu MK, Damodaran S, Solomon J, et al (2004). Distribution of ABO blood groups in acute leukaemias and lymphomas. Ann Hematol, 83, 584-7.
- Walter RB, Othus M, Burnett AK, et al (2013). Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients. Blood, 121, 2424-31. https://doi.org/10.1182/blood-2012-10-462440
- Ziaei JE (2004). High frequency of acute promyelocytic leukemia in northwest Iran. Asian Pac J Cancer Prev, 5, 188-9.